Fort HealthCare Partners with Ivenix to Provide Unprecedented Infusion Safety

3 years ago

Award-winning organizations partner to advance medication safety, clinical outcomes, and operational efficiency BOSTON--(BUSINESS WIRE)--#Ivenix--Ivenix, Inc., a medical technology company with…

Kern Health Systems Selects CitiusTech’s FAST+ FHIR Solution to Comply with the CMS Interoperability and Patient Access Final Rule and Provide Secure, Real-Time Data Access to Members

3 years ago

PRINCETON, N.J.--(BUSINESS WIRE)--Kern Health Systems (KHS), known as Kern Family Health Care, is the largest health plan in Kern County,…

Kareo’s New Automated Patient Billing Feature Modernizes Patient Revenue Collection and Saves Time for Office Staff

3 years ago

Mid-size Billing Company in Massachusetts Is Using Latest Feature in Kareo Patient Collect to Make Tracking and Collecting of Outstanding…

Outperforming The Market: CLS Holdings USA, Inc. Reports Its Second Quarter Results with Latest 10Q

3 years ago

LAS VEGAS, NV / ACCESSWIRE / January 13, 2022 / CLS Holdings USA, Inc. (OTCQB:CLSH)(CSE:CLSH), the ''Company'' or ''CLS'', a…

Spago Nanomedicals Phase 1 Study with SpagoPix Shows Clear Contrast Enhancement and is Expanded into New Indications

3 years ago

LUND, SWEDEN / ACCESSWIRE / January 13, 2022 / Spago Nanomedical (STO:SPAGO.ST) (FRA:7UX.F)Spago Nanomedical AB (publ) today announced that interim…

XPhyto signs Distribution Agreement for Czech Republic, rollout planned for Hungary, Slovakia, Ukraine and Russia

3 years ago

VANCOUVER, CANADA, and UTTENWEILER, GERMANY / ACCESSWIRE / January 13, 2022 / XPhyto Therapeutics Corp. (CSE:XPHY)(OTC:XPHYF)(FSE:4XT) ("XPhyto" or the "Company")…

Abivax Receives EMA Scientific Advice Supportive of Moving ABX464 into Phase 3 Clinical Testing in Ulcerative Colitis

3 years ago

The responses from the European Medicines Agency (EMA) within the scientific advice meeting support moving 25mg and 50mg ABX464 into…

Angle PLC Announces Update on Lab Accreditation and Ovarian Study

3 years ago

First submissions made in relation to accreditation of ANGLE clinical laboratoriesOvarian cancer study sample analysis slower than plannedGUILDFORD, SURREY /…

Nfl Biosciences: Half-Year Review of the Liquidity Agreement for h2 2021

3 years ago

NFL BIOSCIENCESHALF-YEAR REVIEW OF THE LIQUIDITY AGREEMENT FOR H2 2021 Under the liquidity agreement concerning NFL Biosciences SA shares (FR0014003XT0…

Zhittya Genesis Medicine Starts Parkinson’s Disease Clinical Trial

3 years ago

LAS VEGAS, Jan. 12, 2022 (GLOBE NEWSWIRE) -- Zhittya Genesis Medicine, Inc. (a private company) (“Zhittya”), announced that it is…